#Moderna says its vaccine shows durable 93% efficacy through 6 months.
Final analysis (median follow-up 5.3 mo):
-Against COVID19: 93.2%
-Against severe COVID19: 98.2%
-Against death: 100%
(Note: All data prior delta) 1/
Further break down of #Moderna efficacy by 2-month segments post 2nd dose; at month 4+, efficacy is 92.4%
#Pfizer vax (by months 4-6) efficacy is 84% - though against severe disease maintains 97%. 2/
Yet it expects antibody levels will start to wane, and with #delta there will be an increase in #breakthrough infections in fully vaccinated; it sees need for #boosters 3/
#Moderna says lab studies show a booster with half the dose of its #covid19 vaccine increases antibody levels against #delta by 42-fold. 4
#Moderna reports top-line findings from phase 2 study of #booster shot, noting neutralizing antibody titers had waned significantly by 6 months; Safety profile of dose 3 was similar to that of dose 2. 5/
The @WHO yesterday called for a moratorium on #boosters until September to enable countries that haven't had vaccine access to be able to administer first shots. 6/
A NEW study revealed previously unrecognized complement dysregulation associated with impaired cell death and clearance of damaged cells, which may promote nonresolvable (NR) COVID-19 in patients, ultimately necessitating lung transplantation. 1/
Researchers analyzed complement activation in NR-COVID-19 lungs and its association with aberrant host autophagic response. It is the first study to comprehensively show the local presence of the components of the three pathways and regulators of complement activation 2/
The researchers are also the first to investigate the involvement of autophagic mediators as a potential mechanism underlying dysregulated complement-induced tissue damage leading to end-stage respiratory failure. 3/
Antibiotics save lives, but they also wreak havoc on the beneficial bacteria that inhabit the human gut. Innovative therapies could shield the microbiome from their effects. 1/
Researchers have genetically engineered bacteria and nutritional yeast to carry an enzyme that breaks down amoxicillin in the gut without affecting the antibiotic’s ability to fight infection elsewhere in the body. 2/
Other scientists have found that high- fibre diets allay antibiotics’ effects on the gut by changing how intestinal microbes metabolize nutrients. 3/
A NEW study showed that kids with #LongCOVID had lung injuries that correlated to specific LongCOVID symptoms and overall loss of blood flow in the lungs. In participants with longCOVID, greater lung perfusion correlated with increased chronic fatigue severity. 1/
Children and teens with #LongCOVID have significant lung abnormalities detected with an advanced form of MRI, called free-breathing phase-resolved functional lung (PREFUL) MRI. 2/
Children with post-COVID-19 symptoms are less likely to undergo chest scans for diagnosis and lung function monitoring than adults with LongCOVID. Lung perfusion, or blood flow in and out of the lungs, is difficult to detect in children. 3/
In efforts to comprehend this complex disorder, recent research on #LongCOVID has illuminated its prevalence, causes, and management techniques. Even today, studies are still investigating the long-term effects of SARS-CoV-2 infection on numerous organ systems. 1/
A review of 180 studies suggests that LongCOVID symptoms like memory problems, poor concentration, & brain fog may be driven by self-sustaining feedback loops involving vascular dysfunction, neuroinflammation & gut-brain axis disruption 2/
Recent study shows that patients with long COVID or similar conditions like ME/CFS often exhibit an enlarged hippocampus compared to healthy individuals, potentially linking brain inflammation to cognitive challenges. 3/
SARS-CoV-2 triggers the production of the antiviral protein IFN-γ, which is associated with fatigue, muscle ache & depression. Recent study shows that in #LongCOVID, IFN-y production persists until symptoms improve, highlighting a potential biomarker & a target for therapies 1/
The study shows that initial infection with SARS-CoV-2 triggers production of the antiviral protein IFN-γ, which is a normal reaction from the immune system. 2/
For most people, when their infection clears, COVID-19 symptoms cease and production of this protein stops, but the researchers found that high levels of IFN-γpersisted in some Long COVID patients for up to 31 months. 3/